Skip to main content
HR 1026 117th Congress House Crime and Law Enforcement Administrative law and regulatory procedures Consumer affairs Criminal justice information and records Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Prescription drugs

LABEL Opioids Act

Introduced: June 23, 2022 Introduced by: Stanton, Greg Democratic · Arizona See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 28, 2021
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Feb 12, 2021
Referred to the Subcommittee on Health.
Feb 11, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 11, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.

What's happening now April 28, 2021

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Related & companion bills 1
  • S 2353 Related bill LABEL Opioids Act of 2021
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 8
All 8 Democratic 4 Republican 2
Manning, Kathy
· Jun 23, 2022
 D
Jayapal, Pramila
Washington · Jun 14, 2022
O'Halleran, Tom
· Jun 7, 2022
 R
Bacon, Don
Nebraska · Mar 15, 2022
 D
Harder, Josh
California · Mar 1, 2022
 D
Hayes, Jahana
Connecticut · Mar 3, 2021
 R
Van Drew, Jefferson
New Jersey · Mar 2, 2021
 D
Scanlon, Mary Gay
Pennsylvania · Feb 22, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 1026: LABEL Opioids Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1026/
MLA
"H.R. 1026: LABEL Opioids Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1026/.
Bluebook (legal)
H.R. 1026, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1026/.
Markdown link
[H.R. 1026: LABEL Opioids Act](https://openamerica.io/bill/117-HR-1026/)
Report a problem